ZYME logo

Zymeworks Inc. (ZYME)

Profile

Full Name

Zymeworks Inc.

Ticker

NASDAQ: ZYME

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 28, 2017

Indexes

Not included

Website

https://www.zymeworks.com

Employees

299

Key Details

Price

$25.10(-3.57%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$76.30M(0.38% YoY)

Annual EPS

-$1.62(6.13% YoY)

PE Ratio

-

Next earnings date

Mar 11, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $25.10
    ZYME price is $25.10

    30-Day Relative Volume

    0.72
    ZYME 30-day relative volume is 0.72

    Price Performance

    Price Most Recent Change

    -3.57%
    ZYME price was down -3.57% on Dec 2, 2025

    Price YTD Change

    +71.45%
    ZYME price is up +71.45% since January 1st

    Price 1-Year Change

    +73.1%
    ZYME price is up +73.1% year-on-year

    Price 3-Year Change

    +231.13%
    ZYME price is up +231.13% over the past 3 years

    Price Range

    Price All-Time High

    $59.03
    ZYME price is currently -57.48% below its historical high of $59.03

    Price 3-Year Low

    $5.76
    ZYME price is currently +335.76% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $1.89B
    ZYME market cap is $1.89 billion

    Market Cap 3-Year Change

    +296.23%
    ZYME market cap is up +296.23% over the past 3 years

    Market Cap All-Time High

    $2.62B
    ZYME market cap is currently -27.64% below its historical high of $2.62 billion

    Market Cap Sector Percentile

    79.32%
    ZYME market cap is higher than 79.32% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +9.45%
    ZYME shares outstanding is up +9.45% year-on-year

    Shares Outstanding 3-Year Change

    +19.66%
    ZYME shares outstanding is up +19.66% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.83
    ZYME beta is 0.83

    200-day SMA

    $14.55
    ZYME price is currently +72.46% above its 200-day simple moving average

    50-day SMA

    $19.38
    ZYME price is currently +29.52% above its 50-day simple moving average

    14-Day RSI

    63.96
    ZYME 14-day relative strength index is 63.96

    Volume

    0.72
    ZYME 30-day relative volume is 0.72

    ATR

    $1.47
    ZYME average true range is $1.47

    10-day Historical Volatility

    59.60%
    ZYME 10-day historical volatility is 59.60%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $76.30M
    ZYME annual revenue is $76.30 million

    Revenue Analysts Estimate

    $123.59M
    ZYME annual revenue is currently -38.26% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +0.38%
    ZYME annual revenue is up +0.38% year-on-year

    Revenue Sector Percentile

    66.28%
    ZYME annual revenue is higher than 66.28% of companies in Healthcare sector

    EPS

    EPS

    -$1.62
    ZYME annual earnings per share is -$1.62

    EPS Analysts Estimate

    -$0.87
    ZYME annual earnings per share is currently -85.39% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +6.13%
    ZYME annual earnings per share is up +6.13% year-on-year

    EPS Sector Percentile

    43.74%
    ZYME annual earnings per share is higher than 43.74% of companies in Healthcare sector

    Profit

    Gross Profit

    $65.11M
    ZYME annual gross profit is $65.11 million

    Gross Margin

    85.33%
    ZYME annual gross profit margin is 85.33%

    Operating Profit

    -$119.82M
    ZYME annual operating income is -$119.82 million

    Operating Margin

    -157.03%
    ZYME annual operating profit margin is -157.03%

    Net Income

    -$122.69M
    ZYME annual net profit is -$122.69 million

    Net Margin

    -160.80%
    ZYME annual net profit margin is -160.80%

    Expenses

    Total Expenses

    $196.12M
    ZYME annual total expenses is $196.12 million

    Operating Expenses

    $196.12M
    ZYME annual total operating expenses is $196.12 million

    Cost Of Goods Sold

    $11.19M
    ZYME annual cost of goods sold is $11.19 million

    Selling, General & Administrative Expenses

    $61.50M
    ZYME annual SG&A is $61.50 million

    Depreciation & Amortization

    $11.19M
    ZYME annual D&A is $11.19 million

    Interest Expense

    $0.00
    ZYME annual interest expense is $0.00

    Income Tax

    $6.08M
    ZYME annual income tax is $6.08 million

    EBIT & EBITDA

    EBIT

    -$119.82M
    ZYME annual earnings before interest & taxes is -$119.82 million

    EBITDA

    -$108.62M
    ZYME annual EBITDA is -$108.62 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $463.09M
    ZYME annual total assets is $463.09 million

    Non Current Assets

    $162.64M
    ZYME annual long term assets is $162.64 million

    Current Assets

    $300.45M
    ZYME annual total current assets is $300.45 million

    Cash and Cash Equivalents

    $225.78M
    ZYME annual cash & cash equivalents is $225.78 million

    Accounts Receivable

    $55.81M
    ZYME annual accounts receivable is $55.81 million

    Inventory

    $0.00
    ZYME annual inventory is $0.00

    Liabilities

    Total Liabilities

    $124.32M
    ZYME annual total liabilities is $124.32 million

    Long Term Liabilities

    $20.26M
    ZYME annual total long term liabilities is $20.26 million

    Current Liabilities

    $88.29M
    ZYME annual current liabilities is $88.29 million

    Accounts Payable

    $3.90M
    ZYME annual accounts payable is $3.90 million

    Debt

    Total Debt

    $18.51M
    ZYME annual total debt is $18.51 million

    Total Debt 1-Year Change

    -30.75%
    ZYME annual total debt is down -30.75% year-on-year

    Long Term Debt

    $15.77M
    ZYME annual long term debt is $15.77 million

    Short Term Debt

    $2.74M
    ZYME annual short term debt is $2.74 million

    Equity & Capital

    Shareholders Equity

    $338.77M
    ZYME annual stockholders equity is $338.77 million

    Book Value

    $338.77M
    ZYME annual book value is $338.77 million

    Retained Earnings

    -$830.34M
    ZYME annual retained earnings is -$830.34 million

    Working Capital

    $212.16M
    ZYME annual working capital is $212.16 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$110.04M
    ZYME annual cash from operations is -$110.04 million

    Cash From Operations 1-Year Change

    +6.98%
    ZYME annual cash from operations is up +6.98% year-on-year

    Cash From Investing

    $38.76M
    ZYME annual cash from investing is $38.76 million

    Cash From Investing 1-Year Change

    +118.7%
    ZYME annual cash from investing is up +118.7% year-on-year

    Cash From Financing

    -$20.45M
    ZYME annual cash from financing is -$20.45 million

    Cash From Financing 1-Year Change

    -124.99%
    ZYME annual cash from financing is down -124.99% year-on-year

    CAPEX

    CAPEX

    $3.07M
    ZYME annual capital expenditures is $3.07 million

    CAPEX 1-Year Change

    -24.8%
    ZYME annual capital expenditures is down -24.8% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$113.11M
    ZYME annual free cash flow is -$113.11 million

    Free Cash Flow 1-Year Change

    +7.57%
    ZYME annual free cash flow is up +7.57% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    85.33%
    ZYME annual gross profit margin is 85.33%

    Operating Margin

    -157.03%
    ZYME annual operating profit margin is -157.03%

    Net Margin

    -160.80%
    ZYME annual net profit margin is -160.80%

    ROA & ROE

    ROA

    -23.51%
    ZYME annual return on assets is -23.51%

    ROE

    -30.54%
    ZYME annual return on equity is -30.54%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ZYME price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ZYME price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    5.91
    ZYME price to book ratio is 5.91

    PB Ratio Sector Percentile

    80.37%
    ZYME price to book ratio is higher than 80.37% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    14.07
    ZYME price to sales ratio is 14.07

    PS Ratio Sector Percentile

    75.72%
    ZYME price to sales ratio is higher than 75.72% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.66B
    ZYME enterprise value is $1.66 billion

    Enterprise Value Sector Percentile

    77.35%
    ZYME enterprise value is higher than 77.35% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -28.70
    ZYME EV/EBITDA is -28.70

    EV/EBITDA Sector Percentile

    5%
    ZYME EV/EBITDA is higher than 5% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    3.40
    ZYME annual current ratio is 3.40

    Quick Ratio

    3.40
    ZYME annual quick ratio is 3.40

    Leverage

    Debt To Equity

    0.05
    ZYME annual debt to equity ratio is 0.05

    Interest Coverage Ratio

    -
    ZYME annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    5
    ZYME piotroski f-score is 5

    Altman Z-Score

    6.48
    ZYME altman z-score is 6.48

    Analyst ratings

    Recent major analysts updates

    Nov 21, 25 B. Riley Securities
    Buy
    Nov 19, 25 Wells Fargo
    Equal-Weight
    Nov 19, 25 Stifel
    Buy
    Nov 18, 25 HC Wainwright & Co.
    Buy
    Nov 7, 25 Wells Fargo
    Equal-Weight
    Oct 16, 25 JP Morgan
    Overweight
    Oct 14, 25 HC Wainwright & Co.
    Buy
    Oct 10, 25 B. Riley Securities
    Buy
    Aug 11, 25 Citigroup
    Buy
    Jul 3, 25 HC Wainwright & Co.
    Neutral

    Institutional Ownership

    Screeners with ZYME included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Zymeworks Inc.?
    • Does Zymeworks Inc. pay dividends?
    • What sector is Zymeworks Inc. in?
    • What industry is Zymeworks Inc. in?
    • What country is Zymeworks Inc. based in?
    • When did Zymeworks Inc. go public?
    • Is Zymeworks Inc. in the S&P 500?
    • Is Zymeworks Inc. in the NASDAQ 100?
    • Is Zymeworks Inc. in the Dow Jones?
    • When was Zymeworks Inc.'s last earnings report?
    • When does Zymeworks Inc. report earnings?

    What is the ticker symbol for Zymeworks Inc.?

    The ticker symbol for Zymeworks Inc. is NASDAQ:ZYME

    Does Zymeworks Inc. pay dividends?

    No, Zymeworks Inc. does not pay dividends

    What sector is Zymeworks Inc. in?

    Zymeworks Inc. is in the Healthcare sector

    What industry is Zymeworks Inc. in?

    Zymeworks Inc. is in the Biotechnology industry

    What country is Zymeworks Inc. based in?

    Zymeworks Inc. is headquartered in United States

    When did Zymeworks Inc. go public?

    Zymeworks Inc.'s initial public offering (IPO) was on April 28, 2017

    Is Zymeworks Inc. in the S&P 500?

    No, Zymeworks Inc. is not included in the S&P 500 index

    Is Zymeworks Inc. in the NASDAQ 100?

    No, Zymeworks Inc. is not included in the NASDAQ 100 index

    Is Zymeworks Inc. in the Dow Jones?

    No, Zymeworks Inc. is not included in the Dow Jones index

    When was Zymeworks Inc.'s last earnings report?

    Zymeworks Inc.'s most recent earnings report was on November 6, 2025

    When does Zymeworks Inc. report earnings?

    The next expected earnings date for Zymeworks Inc. is March 11, 2026
    On this page